Motilal Oswal Financial Services has reiterated its BUY call on Laurus Labs, highlighting a robust earnings trajectory and strategic capital deployment in CDMO and generics segments.
Prabhudas Lilladher has initiated a BUY call on Ajanta Pharma, urging investors to seize this opportunity based on the company’s robust branded generics (BGx) franchise, promising financial perform
Geojit Investments has issued an Accumulate rating on Granules India Limited, maintaining a revised target price of Rs 630, reflecting a potential upside of around 16% from the cur
MIT scientists have harnessed generative AI to revolutionize antibiotic discovery, unveiling two novel compounds capable of combating drug-resistant gonorrhoea and MRSA.
